Literature DB >> 9498286

Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse.

G Biozzi1, O G Ribeiro, A Saran, M L Araujo, D A Maria, M De Franco, W K Cabrera, O A Sant'anna, S Massa, V Covelli, D Mouton, T Neveu, M Siqueira, O M Ibanez.   

Abstract

Two distinct bidirectional selective breedings for quantitative traits were initiated from identical genetically heterogeneous mouse populations. The resulting lines are characterized by maximal or minimal acute inflammatory responsiveness (AIR): AIRmax and AIRmin lines, respectively, and by resistance or susceptibility to chemical skin tumorigenesis: Car-R and Car-S lines, respectively. The AIR response to s.c. injection of polyacrylamide microbeads, measured by cell content in the local exudate, was 10 times higher in AIRmax than in AIRmin mice. The response to selection was asymmetrical: the realized heritability was 0.26 in AIRmax and 0.008 in AIRmin, and resulted from the additive effect of 7-11 quantitative trait loci (QTL). Low responsiveness was globally dominant in F1 and 48% of F2 segregant variance was found to be due to genetic factors. These findings are the first demonstration of innate regulation of AIR by germ line genes. Susceptibility to skin tumorigenesis induced by a two-stage initiation (DMBA)-promotion (TPA) protocol was lower in AIRmax mice than in AIRmin mice, a 6-fold difference in tumor induction rate. Intense AIR was found to be associated with resistance, and low AIR with susceptibility to tumorigenesis, in F2 segregants chosen for extreme AIR phenotypes. At least some of the AIR QTLs therefore contain genes controlling tumorigenesis. Tumor phenotypes differed more in Car-R and Car-S than in AIRmax and AIRmin lines, indicating that QTLs unrelated to AIR, contribute to the host response to tumorigenesis. The extreme phenotypes/genotypes of the four selected lines and the known genetic constitution of their foundation population, offer new possibilities to discriminate the genes/mechanisms controlling two important traits: AIR and response to chemical tumorigenesis. Collaborative projects will be favorably considered. The description of tumor resistance genes in AIRmax and Car-R mice may be helpful for epidemiology and therapy of human cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9498286     DOI: 10.1093/carcin/19.2.337

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

Review 1.  Defense of the bovine mammary gland by polymorphonuclear neutrophil leukocytes.

Authors:  Max Paape; Jalil Mehrzad; Xin Zhao; Johann Detilleux; Christian Burvenich
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response.

Authors:  Maria F Silva; Alice O Kamphorst; Elize A Hayashi; Maria Bellio; Claudia R Carvalho; Ana M C Faria; Kátia C C Sabino; Marsen G P Coelho; Alberto Nobrega; Daniel Tavares; Antonio C Silva
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

3.  Slc11a1 (Nramp-1) gene modulates immune-inflammation genes in macrophages during pristane-induced arthritis in mice.

Authors:  Mara A Correa; Tatiane Canhamero; Andrea Borrego; Iana S S Katz; José R Jensen; José Luiz Guerra; Wafa H K Cabrera; Nancy Starobinas; Jussara G Fernandes; Orlando G Ribeiro; Olga M Ibañez; Marcelo De Franco
Journal:  Inflamm Res       Date:  2017-07-01       Impact factor: 4.575

Review 4.  Modeling cutaneous squamous carcinoma development in the mouse.

Authors:  Phillips Y Huang; Allan Balmain
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

5.  Enhanced natural killer activity and production of pro-inflammatory cytokines in mice selected for high acute inflammatory response (AIRmax).

Authors:  Lindsey Castoldi; Marjorie Assis Golim; Orlando Garcia Ribeiro Filho; Graziela Gorete Romagnoli; Olga Célia Martinez Ibañez; Ramon Kaneno
Journal:  Immunology       Date:  2006-12-08       Impact factor: 7.397

6.  Distinct early inflammatory events during ear tissue regeneration in mice selected for high inflammation bearing Slc11a1 R and S alleles.

Authors:  Tatiane Canhamero; Brandon Reines; Luciana C Peters; Andrea Borrego; Patricia S Carneiro; Layra L Albuquerque; Wafa H Cabrera; Orlando G Ribeiro; Jose R Jensen; Nancy Starobinas; Olga M Ibañez; Marcelo De Franco
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

Review 7.  Acute Inflammation Loci Are Involved in Wound Healing in the Mouse Ear Punch Model.

Authors:  Tatiane Canhamero; Ludmila Valino Garcia; Marcelo De Franco
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-09-01       Impact factor: 4.730

8.  Gene expression profiles of bone marrow cells from mice phenotype-selected for maximal or minimal acute inflammations: searching for genes in acute inflammation modifier loci.

Authors:  Patrícia dos S Carneiro; Luciana C Peters; Francisca Vorraro; Andrea Borrego; Orlando G Ribeiro; Nancy Starobinas; Jose R Jensen; Wafa H K Cabrera; Olga M Ibañez; Marcelo De Franco
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

9.  Distinct gene expression profiles provoked by polyacrylamide beads (Biogel) during chronic and acute inflammation in mice selected for maximal and minimal inflammatory responses.

Authors:  Jussara Gonçalves Fernandes; Tatiane Canhamero; Andrea Borrego; José Ricardo Jensen; Wafa Hanna Cabrera; Mara Adriana Correa; Nancy Starobinas; Orlando Garcia Ribeiro; Olga Martinez Ibañez; Marcelo De Franco
Journal:  Inflamm Res       Date:  2016-01-28       Impact factor: 4.575

10.  Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.

Authors:  Antonio Brú; Juan-Carlos Souto; Sonia Alcolea; Rosa Antón; Angel Remacha; Mercedes Camacho; Marta Soler; Isabel Brú; Amelia Porres; Luis Vila
Journal:  Mediators Inflamm       Date:  2010-02-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.